PharmaValthos Raises $30 Million for Next-Gen Biodefense
Valthos is planning to build "the tech stack for biodefence"
founders fund
Deployed's enterprise AI reporting on founders fund.
PharmaPharmaDeployed's enterprise AI reporting on founders fund.